SEC Form D · filed October 31, 2016
CURE PHARMACEUTICAL Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Ed Maliski · Oxnard, CADirectorWayne Nasby · Oxnard, CADirectorVic Branstetter · Oxnard, CADirectorRob Davidson · Oxnard, CAExec · DirectorIan Sephton · Oxnard, CADirectorMark Udell · Oxnard, CAExecLuke Ledbetter · New York, NYDirectorVic Branstetter · Oxnard, CADirectorAlex Maffeo · New York, NYDirectorPatrick Hutchines · Luxembourg, LuxembourgExecAndrew Lerner · New York, NYExec · DirectorCarle D. Stenmark · San Francisco, CADirectorBob Glosson · Durham, NCExec · DirectorBarry Boniface · Durham, NCDirectorJerry Nowlin · Durham, NCDirectorMark Feidler · Durham, NCDirectorJack Barry · Durham, NCExecJohn L. King, Jr · Fort Worth, TXDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗